Sarepta Therapeutics Inc. shares plunged after a trial designed to confirm the benefits of two of its older drugs failed to show clear patient improvement, raising questions about their future. The ...
A new blood test could speed up diagnosis and treatment for people dealing with early memory or thinking changes. The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to ...
The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
In a recent study published in JAMA Neurology, an international team of researchers evaluated whether plasma phosphorylated tau 217 (p-tau217) could classify amyloid β (Aβ) status in cognitively ...
This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. The first hints that Gregory Nelson might ...
TORONTO — An expert panel convened by the Alzheimer’s Association has released the first clinical guidelines to help clinicians choose the most appropriate blood-based biomarker (BBM) test to aid in ...
New mothers say they had to undergo devastating investigations after hospitals reported their false positive drug tests to child welfare agencies shortly after they gave birth. This report is ...
Georgia Power and Mitsubishi Power successfully completed a test blending 50% hydrogen and natural gas at Plant McDonough-Atkinson, resulting in a 22% CO2 emissions reduction. This demonstration is ...
The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not. By Pam Belluck A blood test that can help diagnose Alzheimer’s disease has received ...
Please provide your email address to receive an email when new articles are posted on . A seated saline suppression test had a high false-negative rate for predicting response to primary aldosteronism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback